Abstract
Cervical cancer is the third most leading cancer among women, is more prevalent in rural population. The rate and incidence of cervical cancer has declined due to HPV vaccination, screening and education. At present quadrivalent vaccine GARDASIL and bivalent vaccine CERVARIX are available in many countries where as in US the only available vaccine is GRADASIL-9 due to its more efficiency than quadrivalent and bivalent vaccine. Surgery and radiation are considered are best treatment for cervical cancer either individually or in combination. New immunotherapy has also discovered for treatment of cervical cancer.
References
- Prabhdeep Kaur, Ravi Mehrotra, Human papillomavirus vaccine for cancer cervix prevention: Rationale and recommendations for implementation in India Indian Journal of Medical Research, August 2017, DOI: 10.4103/ijmr
- Zheng Hu, Ding Ma The precision prevention and therapy of HPV- related cervical cancer: new concepts and clinical implications Department of Gynecological oncology 21 March 2018
- Phillip E. Castle Dan Murokora Treatment of Cervical intraepithelial lesions International Journal of Gynecology and obstetrics 2017 DOI: 10.1002
- Birgitte Baldur-Felskov, Christian Dehlendorff Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia- Nationwide Follow-Up of Yound Danish Women Vol.106, Issue 3 March 12, 2014
- Gauravi A. Mishra Sharmila A. Pimple Prevention of Cervix Cancer in India Department of Preventive Oncology July 28, 2016
- Anand Narain Srivastava, Jata Shankar Misra, Cervical cancer screening in rural India: status and current concepts . Indian journal of medical research, December 2018, DOI:10.4103/ijmr.
- Aswathy Sreedevi, Reshma Javed, Epidemiology of cervical cancer with special focus on India, International Journal of Women’s Health 2015,unported, v3.0
- Ashlesha Deverakonda and Neha Gupta,Diagnosis and Treatment of Cervical cancer: A Review,Research and Review Journal of Nursing and Health Sciences Accepted: 6/09/2016
- Salina zhang,BS, Human Papillomavirus in 2019: An update on cervical cancer prevention and screening guidelines, Cleveland Clinic Journal of Medicine Volume 86. Number3, march2019, DOI: 10.3949/ccjm .
- Efthimios Deligeoroglou, Aikaterini Giannouli, HPV Infection: Immunological Aspects and Their Utility in Future Therapy, Infectious Diseases in Obstetrics and Gynecology volume 2013, Accepted 18 July2013.
- Okechukwu A. Ibeanu, Molecular Pathogenesis of Cervical Cancer February 1, 2011, Cancer Biology and therapy DOI: 10.4161/cbt
- Simona Roxana Georgescu, Cristina Iulia Mitran, New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress, Journal of Immunology Research volume 2018 Published 27 August 2018
- Raffaella Ghittoni, Rosita Accardi, Role of Human Papillomavirus in Carcinogenesis, eCancer Medical Science, Published 29/04/2015, DOI:10.3332/ecancer.
- Tanja Sarenac and Momir Mikov, Cervical Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This Disease, Frontiers in Pharmacology, Published 04 June 2019, DOI: 10.3389/fphar.
- Edith Borcoman and Christophe Le Tourneau, Pembrolizumab in cervical cancer: latest evidence and clinical usefulness, Therapeutic Advances in Medical Oncology, There Advance Medical Oncology 2017, Vol 9, revised manuscript accepted: 18 April 2017.
Corresponding Author
Dr P. Kishore
Head, Department of Pharmacy Practice, Care College of Pharmacy, Oglapur (v), Damera (m),
Warangal Rural, Telangana, India – 506006
DOI: https://dx.doi.org/10.18535/jmscr/v7i12.126
